Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.20 +0.00 (+0.00%)
As of: Oct 21, 2026 · 3:59 PM EDT

Eloxx Pharmaceuticals (ELOX) Receivables - Other (2016 - 2024)

Updated

Eloxx Pharmaceuticals (ELOX) recorded Receivables - Other of $359,000 in Q4 2024.

Analysis

Eloxx Pharmaceuticals (ELOX) Receivables - Other (2016 - 2024) Analysis & Trends

Starting with Q4 2016, Eloxx Pharmaceuticals' Receivables - Other history includes 4 quarters.

  • The Q4 2024 figure is the highest quarterly Receivables - Other since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Eloxx Pharmaceuticals 89.68 Mn 16.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 359,000.00
Mar 31, 2021 3.40 Mn
Sep 30, 2019 403,000.00
Dec 31, 2016 605,000.00
API Access

Eloxx Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ELOX&period=max&api_key=YOUR_API_KEY